Roth MKM analyst John White raised the firm’s price target on Vitesse Energy (VTS) to $30.50 from $27.75 and keeps a Buy rating on the shares ahead of its Q4 results. The firm is adjusting its ...

Annovis Bio (ANVS) announced that the first two patients have been entered into the Phase 3 study evaluating buntanetap in early AD. “The launch of our highly anticipated AD study is a significant ...